✦ LIBER ✦

Unique antipsychotic profile of a novel 5-HT2A receptor antagonist and dopamine receptor protein phosphorylation modulator

✍ Scribed by L.P. Wennogle; G.L. Snyder; J.P. Hendrick; K.E. Vanover; J.T. Tomesch; P. Li; J.P. O'callaghan; D.B. Miller; A.A. Fienberg; R.E. Davis; S. Mates

Book ID: 119363387
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 60 KB
Volume: 98
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2007.12.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atypical Antipsychotic Profile of NRA004

Atypical Antipsychotic Profile of NRA0045, a Novel Dopamine D4 receptor, 5-Hydroxytryptamine2A (5-HT2A) Receptor and α1 Adrenoceptor Antagonist

✍ Shigeyuki Chaki; Atsuro Nakazato; Shigeru Okuyama 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Receptor binding profile of R 41 468, A

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

✍ J.E. Leysen; F. Awouters; L. Kennis; P.M. Laduron; J. Vandenberk; P.A.J. Janssen 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 485 KB

The atypical antipsychotic profile of NR

The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats

✍ Shigeru Okuyama; Shigeyuki Chaki; Naoya Kawashima; Yoshiko Suzuki; Shin-ichi Oga 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 394 KB

Atypical antipsychotic properties of blo

Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist

✍ Yukihiro Ohno; Motoki Okano; Junta Imaki; Ayaka Tatara; Takahiro Okumura; Saki S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 413 KB

L-683,877: Pharmacological profile of a

L-683,877: Pharmacological profile of a novel 5-HT3 receptor antagonist

✍ Dr. David Tattersall; Nigel Newberry; Margaret S. Beer; Mike Rigby; Michael Gilb 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Neurochemical profile in vitro of irinda

Neurochemical profile in vitro of irindalone: A5-HT2-receptor antagonist

✍ John Hyttel; Klaus BøGesø; Hanne LøVe LembøL; Jens-JøRgen Larsen; Eddi Meier 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 866 KB

A new potential antihypertensive drug, irindalone (Lu 21 -098;( +)-(1 R,3S)-1-[2-[4-[3-(pf luoropheny1)-1 -indanyl]-1 -piperazinyl]ethyl]-2-imidazolidinone), has been characterized by a series of in vitro methods. lrindalone competitively inhibits peripheral and central serotonin;! (5-HT2) receptors